Climb Bio (CLYM) Other Operating Expenses (2020 - 2024)

Climb Bio (CLYM) has 5 years of Other Operating Expenses data on file, last reported at $2.8 million in Q3 2024.

• Quarterly Other Operating Expenses rose 120.86% year-over-year to $2.8 million in Q3 2024, while the trailing twelve-month figure through Jun 2025 was $2.8 million (up 1.42% YoY) and the FY2024 annual result came in at $51.7 million, changed N/A from the prior year.
• Other Operating Expenses improved to $2.8 million in Q3 2024, from $1.5 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $9.4 million in Q4 2020 to a low of $20000.0 in Q3 2021.
• A 5-year average of $1.6 million and a median of $900000.0 in 2023 frame the typical range for Other Operating Expenses.
• Annual changes were most pronounced in 2021 — Other Operating Expenses tumbled 99.36% — and 2023, when it jumped 958.82%.
• Tracing CLYM's Other Operating Expenses over 5 years: stood at $9.4 million in 2020, then plunged by 99.36% to $60000.0 in 2021, then surged by 41.67% to $85000.0 in 2022, then soared by 1383.53% to $1.3 million in 2023, then jumped by 120.86% to $2.8 million in 2024.
• The last three Other Operating Expenses figures came in at $2.8 million (Q3 2024), $1.5 million (Q2 2024), and $1.3 million (Q3 2023), per Business Quant data.